Skip to Main Content

Good morning, everyone, and welcome to another working week. We hope the weekend respite was refreshing and invigorating, because that oh-so-familiar routine of meetings, deadlines, and the like has, of course, returned. You knew this would happen, yes? Well, one way to cope is to fire up your coffee kettle — or stop by a trusty cafe — and quaff a cup or two of stimulation. Your neurons will thank you. Meanwhile, here are some tidbits, which you may consider to be another form of stimulation. Hope all goes well today and, as always, do keep in touch …

The federal government, which has been accused of failing to hold drug companies to account for the deadly opioid epidemic, hopes to dispel that impression Monday when the first criminal trial of pharmaceutical executives who marketed a painkiller begins, the Boston Globe writes. John Kapoor, a onetime billionaire and founder of Insys Therapeutics (INSY), is scheduled to go on trial in federal court in Boston along with four former company executives on charges they acted more like mobsters when they sold Subsys, a brand of fentanyl, a powerful and addictive opioid.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!